About this trial
Multicentre randomised trial evaluating extended thromboprophylaxis with low molecular weight heparin for 28 days following major vascular surgical procedures.
Recruiting
Prevention of VTE Following Major Vascular Surgery
PREVENT-VTE
Intervention
Extended-Duration Low Molecular Weight Heparin
Eligibility
This trial is investigating treatments for Venous Thromboembolism. Detailed age range and eligibility criteria will be published with the patient information pack.
Funding
Funding details for this trial are being finalised and will be published here shortly.
View patient-friendly version of this trial →